Johnson & Johnson's stock (JNJ) dipped 0.22% and settled at 176.37, with trading volumes at 6.4 million shares, while seeking a bottom to bounce it higher anew, amid the dominance of the main upward trend in the medium term, with positive signals from the RSI after reaching oversold levels.

The drop came after US regulators restricted the use of the company's vaccine due to rare blood clots concerns. 

Analysts expect the stock to return higher, targeting the first resistance at 179.50.

Open Real Trading Account

Expected trend for today: Bullish